ArticleBMJ open2026
Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study.
Rebekka Rust et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.